SOPs for Liposome and Emulsion Formulations

The purpose of this SOP is to outline the procedure for preparing double emulsions, such as water-in-oil-in-water (W/O/W) and oil-in-water-in-oil (O/W/O) emulsions. Double emulsions are complex emulsions where an internal phase is dispersed within an external phase, which is in turn dispersed within a continuous phase. These emulsions are used in controlled-release formulations and for encapsulating hydrophilic or hydrophobic substances. This SOP ensures the stability and consistency of double emulsions for pharmaceutical, cosmetic, or food applications.
Click to read the full article.

The purpose of this SOP is to outline the procedure for the selection and use of emulsifiers in emulsion formulations. Emulsifiers are critical agents that stabilize emulsions by reducing the interfacial tension between immiscible liquids, such as oil and water. This SOP describes how to select the appropriate emulsifier based on the emulsion type, and how to incorporate them into the formulation to ensure the stability, consistency, and homogeneity of the emulsion.
Click to read the full article.

The purpose of this SOP is to outline the process for preparing microemulsions, which are clear, thermodynamically stable dispersions of oil and water stabilized by surfactants and cosurfactants. Microemulsions are used in various pharmaceutical, cosmetic, and food applications due to their ability to solubilize both hydrophobic and hydrophilic ingredients, providing enhanced stability and controlled release. This SOP ensures the consistency, stability, and transparency of the microemulsion.
Click to read the full article.

This SOP outlines the procedure for formulating Self-Emulsifying Drug Delivery Systems (SEDDS), which are lipid-based formulations designed to improve the bioavailability of poorly water-soluble drugs. SEDDS formulations spontaneously emulsify into fine oil-in-water emulsions when exposed to gastrointestinal fluids, enhancing drug solubilization and absorption.
Click to read the full article.

The purpose of this SOP is to describe the procedure for using high-shear mixing to prepare emulsions. High-shear mixing ensures the formation of stable emulsions by reducing droplet size and providing uniform mixing. This technique is commonly employed to prepare emulsions for pharmaceutical, cosmetic, and food products, where consistent droplet size and stability are critical.
Click to read the full article.

The purpose of this SOP is to describe the process for formulating thermosensitive liposomes, which are designed to release their contents in response to temperature changes. Thermosensitive liposomes are commonly used in drug delivery systems, particularly in cancer therapies where heat can trigger the localized release of drugs at the tumor site. This SOP outlines the steps for preparing liposomes that are stable at physiological temperatures and release drugs when exposed to hyperthermic conditions.
Click to read the full article.

The purpose of this SOP is to describe the process for formulating pH-responsive emulsions, which are designed to release active ingredients when exposed to specific pH conditions. These emulsions are widely used in pharmaceutical and cosmetic applications, where controlled drug release based on pH is required, such as in targeted drug delivery for gastrointestinal conditions.
Click to read the full article.

The purpose of this SOP is to describe the procedure for optimizing droplet size in emulsion formulations. Droplet size significantly affects the stability, appearance, and bioavailability of emulsions, especially in pharmaceutical, cosmetic, and food applications. Optimizing droplet size ensures the emulsion remains stable and functional throughout its intended shelf life.
Click to read the full article.

The purpose of this SOP is to outline the procedure for preparing emulsions intended for parenteral administration. Parenteral emulsions are used for delivering drugs directly into the bloodstream, bypassing the digestive system, and are commonly used for intravenous, intramuscular, or subcutaneous administration. These emulsions must meet strict sterility, particle size, and stability criteria to ensure patient safety and efficacy.
Click to read the full article.

The purpose of this SOP is to describe the process for incorporating active pharmaceutical ingredients (APIs) into liposomes, which are widely used in drug delivery systems. Liposomes enhance the solubility, stability, and bioavailability of APIs by encapsulating them within lipid bilayers, making them suitable for controlled and targeted release.
Click to read the full article.